Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/15867215

Clin. Cancer Res. 2005 May 1 11 9 3210-6

Download in:

View as

General Info

PMID
15867215